Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells

Abstract Human bone marrow‐derived mesenchymal stem/stromal cells (BM‐MSCs) represent promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the results of autologous BM‐MSC administration in T2DM patients are contradictory. The purpose of this study was to test the hy...

Full description

Bibliographic Details
Main Authors: Liem Thanh Nguyen, Duc M. Hoang, Kien T. Nguyen, Duc M. Bui, Hieu T. Nguyen, Hong T.A. Le, Van T. Hoang, Hue T. H. Bui, Phuong T.M. Dam, Xuan T.A. Hoang, Anh T.L. Ngo, Hang M. Le, Nhi Y. Phung, Duc M. Vu, Trung T. Duong, Tu D. Nguyen, Lien T. Ha, Hoa T.P. Bui, Hoa K. Nguyen, Michael Heke, Anh V. Bui
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Stem Cells Translational Medicine
Subjects:
autologous
autologous stem cell transplantation
bone marrow
diabetes
Online Access:https://doi.org/10.1002/sctm.20-0506

Internet

https://doi.org/10.1002/sctm.20-0506

Similar Items